Post-approval studies (Phase 4)Study completedNCT00526305
What this trial is testing
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 100